The role of placental trophoblast in the pathophysiology of the antiphospholipid antibody syndrome

American Journal of Reproductive Immunology

Volumn 39, Issue 2, 1998, Pages 125-136

  Rote, Neal S ^a   Vogt, Elizabeth ^a   Devere, Gabrielle ^a   Obringer, Amy R ^a   Ng, A H Kau ^b  

^a WRIGHT STATE UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTHERN MAINE   (United States)

Author keywords

Annexin V; Antiphospholipid antibodies; Choriocarcinoma; Phosphatidylserine; Trophoblast

Indexed keywords

LIPOCORTIN 5; PHOSPHATIDYLSERINE; PHOSPHOLIPID ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; PATHOPHYSIOLOGY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; TROPHOBLAST;

EID: 0031975690     PISSN: 87558920     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0897.1998.tb00344.x     Document Type: Article

References (63)

1. Lechner K: Lupus anticoagulants and thrombosis. In Thrombosis and Haemostasis, M Verstraete, J Vermylen, R Lijnen, J Arnout (eds). Leuven, Belgium, Leuven University Press, 1987, pp 525-547.
2. Triplett DA, Brandt JT, Musgrave KA, Orr CA: The relationship between lupus anticoagulants and antibodies to phospholipid. JAMA 1988; 259:550-554.
3. Branch DW, Scott JR: Clinical implications of anti-phospholipid antibodies: The Utah experience. In Phospholipid-Binding Antibodies, EN Harris, T Exner, GRV Hughes, RA Asherson (eds). Boca Raton, FL, CRC Press, 1991, pp 335-346.
4. Branch DW, Andres R, Digre KB, Rote NS, Scott JR: The association of antiphospholipid antibodies with severe preeclampsia. Obstet Gynecol 1981; 73:541-545.
5. Francois A, Freund M, Daffos F, Remy P, Aiach M, Jacquot C: Repeated fetal losses and the lupus anticoagulant. Ann Intern Med 1988; 109:993-994.
6. Kochenour NK, Branch DW, Rote NS, Scott JR: A new postpartum syndrome associated with antiphospholipid antibodies. Obstet Gynecol 1987; 69:460-468.
7. DeWolf F, Carreras LO, Moerman P, Vermylen J, Van Assche A, Renaer M: Decidual vasculopathy and extensive placenial infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant. Am J Obstet Gynecol 1982; 142:829-834.
8. Out HJ, Kooijman CD, Bruinse HW, Derksen RHWM: Histopathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodies. Eur J Obstet Gynecol Reprod Biol 1991; 41:179-186.
9. Lochshin MD, Druzin ML, Goei S, Qamar T, Magid MS, Jovanovic L, Ferene M: Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. N Engl J Med 1985; 313:152-156.
10. Althabe O, Labarrere C, Telenta M: Maternal vascular lesions in placentae of small-for-gestational-age infants. Placenta 1985; 6:265-276.
11. Sheppard BL, Bonnar J: An ultrastructural study of utero- placental spiral arteries in hypertensive and normotensive pregnancy and fetal growth retardation. Br J Obstet Gynecol 1981; 88:695-705.
12. Abramowsky CR, Vegas ME, Swinehart G, Gyves MT: Decidual vasculopathy of the placenta in lupus erythematosus. N Engl J Med 1980; 303:668-672.
13. Ioannou PV, Golding BT: Cardiolipins: Their chemistry and biochemistry. Prog Lipid Res 1979; 17:279-318.
14. Daum G: Lipids of mitochondria. Biochim Biophys Acta 1985; 822:1-42.
15. Dale MP, Robinson NC: Synthesis of cardiolipin derivatives with protection of the free hydroxyl: its application to the study of cardiolipin stimulation of cytochroine c oxidase. Biochem 1988; 27:8270-8275.
16. Schick PK, Kurica KB, Chacko GK: Localization of phosphatidylethanolamine and phosphatidylserine in the human platelet plasma membrane. J Clin Invest 1976; 57:1221- 1226.
17. Op den Kamp JAF: Lipid asymmetry in membranes. Ann Rev Biochem 1979; 48:47-71.
18. Nakashima S, Suganuma A, Matsui A, Nozawa Y: Thrombin induces a biphasic 1,2-diacyl glycerol production in human platelets. Biochem J 1991; 275:355-361.
19. Branch DW, Rote NS, Scott JR: The demonstration of the lupus anticoagulant by an enzyme-linked immunosorbant assay (ELISA). Clin Immunol Immunopathol 1986; 39:296-307.
20. Branch DW, Rote NS, Dostal DA, Scott JR: Association of lupus anticoagulant with antibody against phosphatidylserine. Clin Immunol Immunopathol 1987; 42:63-75.
21. McEvoy L, Williamson P, Schlegel RA: Membrane phospholipid asymmetry as a determinant of erythrocyte recognition by macrophages. Proc Natl Acad Sci USA 1986; 83:3311-3315.
22. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM: Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992; 148:2207- 2216.
23. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH: Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994; 84:1415-1420.
24. Sessions A, Horowitz AF: Myoblast aminophospholipid asymmetry differs from that of fibroblasts. FEBS Lett 1981; 134:75-78.
25. Sessions A, Horowitz AF: Differentiation related differences in the plasma membrane phospholipid asymmetry of myogenic and fibrogenic cells. Biochim Biophys Acta 1983; 728:103-111.
26. Bevers EM, Galli M, Barbui T, Comfurius P, Zwaal RFA: Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemost 1983; 66:629-632.
27. Zwaal RFA, Bevers EM, Comfurius P, Rosing J, Tilly RH, Verhallen PF: Loss of membrane phospholipid asymmetry during activation of blood platelets and sickled red cells; mechanisms and physiological significance. Mol Cell Biochem 1989; 91:23-31.
28. Thiagarajan P, Tait JF: Binding of annexin V/placental anticoagulant protein I to platelets. Evidence for phosphatidylserine exposure in the procoagulant response of activated platelets. J Biol Chem 1990; 265:17420-17423.
29. Rote NS, Ng AK, Dostal-Johnson DA, Nicholson SL, Siekman R: Immunologic detection of phosphatidylserine externalization during thrombin-induced platelet activation. Clin Immunol Immunopathol 1993; 66:193-200.
30. Adler RR, Ng AK, Rote NS: Monoclonal antiphosphatidylserine antibody inhibits intercellular fusion of the choriocarcinoma line, JAR. Biol Reprod 1995; 53:905-910.
31. Rote NS, Chang J, Katsuragawa H, Ng AK, Lyden TW, Mori T: Expression of phosphatidylserine-dependent antigens on the surface of differentiating BeWo human choriocarcinoma cells. Am J Reprod Immunol 1995; 33:114-121.
32. Devaux PF: The aminophospholipid translocase: A transmembrane lipid pump - Physiological significance. NIPS 1990; 5:53-58.
33. Sune A, Bette-Bobillo P, Bienvenue A, Fellmann P, Devaux PF: Selective outside-inside translocation of amino-phospholipids in human platelets. Biochemistry 1987; 26:2972-2978.
34. Zwaal RFA: Scrambling membrane phospholipids and local control of blood clotting. NIPS 1988; 3:57-61.
35. Le DT, Rapaport SI, Rao VM: Studies of the mechanism for enhanced cell surface factor VIIa/tissue factor activation of factor X on fibroblast monolayers after their exposure to N- ethylmaleimide. Thromb Haemost 1994; 72:848-855.
36. Zachowski A, Henry J-P, Devaux PF: Control of transmembrane lipid asymmetry in chromaffin granules by and ATP- dependent protein. Nature 1989; 340:75-76.
37. Zwaal RFA, Bevers EM, Comfurius P: Static and dynamic lipid asymmetry in cell membranes. In Proceedings of the International STAGO Symposium on Phospholipid-Binding Antibodies and Thrombosis, Paris, May 14, 1993, pp 2-3.
38. Kliman HJ, Feinman MA, Strauss JF III: Differentiation of human cytotrophoblasts into syncytiotrophoblasts in culture. Troph Res 1987; 2:407-421.
39. Boyd JD, Hamilton WJ: The Human Placenta. Cambridge, (UK), Hefferand Sons, 1970.
40. Tait JF, Gibson D, Fujikawa K: Phospholipid binding properties of human placental anticoagulant protein-I, a member of the lipocortin family. J Biol Chem 1989; 264:7944-7949.
41. Romisch J, Schorlemmer U, Fickenscher K, Paques EP, Heimburger N. Anticoagulant properties of placenta protein 4 (Annexin V). Thromb Res 1990; 60:355-366.
42. Lyden TW, Vogt E, Ng AK, Johnson PM, Role NS: Monoclonal antiphospholipid antibody reactivity against human placental trophoblast. J Reprod Immunol 1992; 22:1-14.
43. Katsuragawa H, Rote NS, Inoue T, Narukawa S, Kanzaki H, Mori T: Monoclonal antiphosphatidylserine antibody reactivity against human first-trimester placental trophoblasts. Am J Obstet Gynecol 1995; 177:1592-1597.
44. Vogt E, Awaloei H, Ng AK, Rote NS: Reactivity of monoclonal antiphospholipid antibodies with endovascular trophoblast and chorioamnion. Am J Obstet Gynecol, submitted.
45. Hasegawa I, Takakuwa K, Adachi S, Kanazawa K: Cytotoxic antibody against trophoblast and lymphocytes present in pregnancy with intrauterine fetal growth retardation and its relation to anti-phospholipid antibody. J Reprod Immunol 1990; 17:127-139.
46. Blank M, Tincani A, Shoenfeld Y: Induction of experimental antiphospholipid syndrome in naive mice with purified IgG antiphosphatidylserine antibodies. J Rheumatol 1994; 21:100-104.
47. Vogt E, Ng AK, Rote NS: A model for the antiphospholipid antibody syndrome: monoclonal antiphosphatidylserine antibody induces intrauterine growth restriction in mice. Am J Obst Gynecol 1996; 174:700-707.
48. Rote NS, Lyden TW, Vogt E, Ng AK: Antiphospholipid antibodies and placental development. In Immunobiology of Reproduction JS Hunt, (ed). New York, Springer-Verlag, 1994, pp 285-302.
49. Rote NS, Lyden TW, Vogt E, Adler RR, Chang J, Katsuragawa H, Lin L, Ng AK, Nicholson S, Patel PN, Shroyer L, Ponder D: Expression of phosphatidylserine epitopes during trophoblast membrane fusion: An alternative hypothesis for antiphospholipid antibody associated pregnancy disorders. In Reproductive Immunology, Vol 97, F Dondero, PM Johnson (eds). New York, Serono Symposia Publications, Raven Press, 1993, 281-284.
50. Katsuragawa H, Kanzaki H, Inoue T, Hirano T, Mon T, Rote NS: Monoclonal antibody against phosphatidylserine inhibits in vitro human trophoblastic hormone production and invasion. Biol Reprod 1997; 56:50-58.
51. Iwashita M, Watanabe M, Setoyama T, Mimuro T, Nakayama S, Adachi T, Takeda Y, Sakamoto S: Effects of diacylglycerol and gonadotropin-releasing hormone on human chorionic gonadotropin release by cultured trophoblast cells. Placenta 1992; 13:213-221.
52. Shi CZ, Zhuang LZ: Norepinephrine regulates human chorionic gonadotropin production by first trimester trophoblast tissue in vitro. Placenta 1993; 14:683-693.
53. Gleicher N, Harlow L, Zilberstein M: Regulatory effect of antiphospholipid antibodies on signal transduction: A possible model for autoantibody-induced reproductive failure. Am J Obstet Gynecol 1992; 167:637-642.
54. DiSimone N, DeCarolis S, Lanzone A, Rosisvalle E, Giannice R, Caruso A: In vitro effect of antiphospholipid antibody-containing sera on basal and gonadotropin releasing hormone-dependent human chorionic gonadotropin release by cultured trophoblast cells. Placenta 1995; 16:75-83.
55. Reza F, Igarashi K, Tokita S, Asai K, Aoki J, Asaoka Y, Umeda M, Inoue K: Anti-idiotypic monoclonal antibody recognizes a consensus recognition site for phosphatidylserine in phosphatidylserine-specific monoclonal antibody and protein kinase C. FEBS Lett 1994; 339:229-233.
56. Zhou Y, Damsky CH, Chin K, Roberts JM, Fisher SJ: Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts. J Clin Invest 1993; 91:950-960.
57. DeVere G, Ng AK, Rote NS: Monoclonal antiphosphatidylserine antibody prevents the migration of JAR choriocarcinoma through matrigel coated filters. Biol Reprod, submitted.
58. Graham CH, Lala PK: Mechanisms of placental invasion of the uterus and their control. Biochem. Cell Biol 1992; 70:867-874.
59. Bevers EM, Comfurius EP, Van Rijn J, Hemker C, Zwaal RFA: Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface of platelets. Eur J Biochem 1982; 122:429-436.
60. Rand JH, Wu X-X, Culler S, Gil J, Guha A, Scher J, Lockwood CJ: Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion. Am J Obstet Gynecol 1994; 171:1566-1572.
61. Krikun G, Lockwood CJ, Wu X-X, Zhou X-D, Guller S, Calandri C, Guha A, Nemerson Y, Rand JH: The expression of the placental anticoagulant protein, annexin V, by villous trophoblasts: Immunolocalization and in vitro regulation. Placenta 1994; 15:601-612.
62. Vogt E, Ng AK, Rote NS: Anti-phosphatidylserine antibody removes annexin V and facilitates the binding of prothrombin at the surface of a choriocarcinoma model of trophoblast differentiation. Am J Obstet Gynecol, 177:964-972.
63. Andree HA, Stuart MC, Hermens WT, Reutelingsperger CP, Hemker HC, Frederik PM, Willems GM: Clustering of lipid- bound annexin V may explain its anticoagulant effect. J Biol Chem 1992; 267:17907-17912.